POLISCOPE
Back to feed
HR8528FEDERALin_committee

PI Post Acute Access Act (H.R. 8528)

Original title: PI Post Acute Access Act

April 27, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Apr 27, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

Starting October 1, 2026, Medicare coverage rules for skilled nursing facilities will expand to include specific treatments for patients with primary immunodeficiency, potentially changing how these patients receive care in post-acute settings.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Primary immunodeficiency patients

Patients requiring intravenous immune globulin will have these treatments covered under Medicare while in skilled nursing facilities.

Skilled nursing facilities

Facilities will be required to provide or facilitate the administration of specific immune globulin treatments as part of covered Medicare services.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes changes to Medicare coverage to ensure patients with primary immunodeficiency diseases can access specific treatments while staying in skilled nursing facilities. It aims to update the Social Security Act to include these treatments and related services under covered items.

Key Facts

  • The bill is officially titled the 'PI Post Acute Access Act'.
  • It amends Section 1888(e)(2)(A)(iii) of the Social Security Act.
  • The amendment adds intravenous immune globulin treatments for primary immune deficiency disease to the list of covered items in skilled nursing facilities.
  • Specific HCPCS codes covered include J1561, J1569, J1576, J1568, J1459, J1554, J1557, and J1566.
  • The Secretary of Health and Human Services has the authority to modify the list of covered HCPCS codes in the future.
  • The changes apply to items and services furnished on or after October 1, 2026.

Frequently Asked Questions

What does this bill change for Medicare patients?
It allows Medicare to cover specific treatments for primary immunodeficiency patients when they are receiving care in a .
When do these changes take effect?
The changes are scheduled to apply to services provided on or after October 1, 2026.

Why It Matters

Starting October 1, 2026, Medicare coverage rules for skilled nursing facilities will expand to include specific treatments for patients with primary immunodeficiency, potentially changing how these patients receive care in post-acute settings.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Medicare Coverage Expansion

The bill explicitly lists current HCPCS codes while granting the Secretary of Health and Human Services ongoing authority to update the list, indicating a move toward more flexible coverage definitions.

Connected Entities

organizationCommittee on Energy and CommerceHouse committee assigned to review the bill.Map →
otherSocial Security ActThe federal law being amended by this bill.Map →
personMatsuiMember of the House of Representatives who co-sponsored the bill.Map →
organizationCommittee on Ways and MeansHouse committee assigned to review the bill.Map →
personSmith of NebraskaMember of the House of Representatives who introduced the bill.Map →

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record